Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2014. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 73111601000001112 | Tafamidis (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 73111701000001119 | Tafamidis | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tafamidis | Is a | Central nervous system agent | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tafamidis meglumine 20mg capsules | Has specific active ingredient | False | Tafamidis | Inferred relationship | Existential restriction modifier | |
| Vyndaqel 20mg capsules (Pfizer Ltd) | Has specific active ingredient | False | Tafamidis | Inferred relationship | Existential restriction modifier | |
| Tafamidis meglumine 20mg capsules 30 capsule | Has specific active ingredient | False | Tafamidis | Inferred relationship | Existential restriction modifier | |
| Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules | Has specific active ingredient | False | Tafamidis | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets